163 related articles for article (PubMed ID: 37498438)
21. Cytochalasin B-Induced Membrane Vesicles from TRAIL-Overexpressing Mesenchymal Stem Cells Induce Extrinsic Pathway of Apoptosis in Breast Cancer Mouse Model.
Chulpanova DS; Pukhalskaia TV; Gilazieva ZE; Filina YV; Mansurova MN; Rizvanov AA; Solovyeva VV
Curr Issues Mol Biol; 2023 Jan; 45(1):571-592. PubMed ID: 36661524
[TBL] [Abstract][Full Text] [Related]
22. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
[TBL] [Abstract][Full Text] [Related]
23. Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway.
Li T; Zhang Q; Zhang J; Yang G; Shao Z; Luo J; Fan M; Ni C; Wu Z; Hu X
BMC Cancer; 2014 Feb; 14():96. PubMed ID: 24529079
[TBL] [Abstract][Full Text] [Related]
24. Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3.
Abd El-Hafeez AA; Khalifa HO; Mahdy EAM; Sharma V; Hosoi T; Ghosh P; Ozawa K; Montano MM; Fujimura T; Ibrahim ARN; Abdelhamid MAA; Pack SP; Shouman SA; Kawamoto S
Pharmacol Rep; 2019 Apr; 71(2):289-298. PubMed ID: 30826569
[TBL] [Abstract][Full Text] [Related]
25. Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.
Zhen Y; Zhao R; Wang M; Jiang X; Gao F; Fu L; Zhang L; Zhou XL
Theranostics; 2020; 10(18):8080-8097. PubMed ID: 32724459
[No Abstract] [Full Text] [Related]
26. Novel shikonin derivatives suppress cell proliferation, migration and induce apoptosis in human triple-negative breast cancer cells via regulating PDK1/PDHC axis.
Chen Q; Han H; Lin F; Yang L; Feng L; Lai X; Wen Z; Yang M; Wang C; Ma Y; Yin T; Lu G; Lin H; Qi J; Yang Y
Life Sci; 2022 Dec; 310():121077. PubMed ID: 36244412
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines.
Jafari S; Dabiri S; Mehdizadeh Aghdam E; Fathi E; Saeedi N; Montazersaheb S; Farahzadi R
Clin Transl Oncol; 2023 Aug; 25(8):2559-2568. PubMed ID: 36964888
[TBL] [Abstract][Full Text] [Related]
28. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
[TBL] [Abstract][Full Text] [Related]
29. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
[TBL] [Abstract][Full Text] [Related]
30. Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer.
Ding YN; Ding HY; Li H; Yang R; Huang JY; Chen H; Wang LH; Wang YJ; Hu CM; An YL; Zhang ZY; Yu WP; Tang QS; Shao GL
Acta Biomater; 2023 Sep; 167():534-550. PubMed ID: 37302734
[TBL] [Abstract][Full Text] [Related]
31. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling.
Cheng W; Liu D; Guo M; Li H; Wang Q
Drug Dev Res; 2022 Aug; 83(5):1138-1151. PubMed ID: 35426453
[TBL] [Abstract][Full Text] [Related]
32. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway.
Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J
Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitor panobinostat in combination with rapamycin confers enhanced efficacy against triple-negative breast cancer.
Wu K; Zhang H; Zhou L; Chen L; Mo C; Xu S; Lin J; Kong L; Chen X
Exp Cell Res; 2022 Dec; 421(1):113362. PubMed ID: 36152730
[TBL] [Abstract][Full Text] [Related]
34. Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin.
Liang S; Peng X; Li X; Yang P; Xie L; Li Y; Du C; Zhang G
Oncotarget; 2015 Jan; 6(2):1020-30. PubMed ID: 25544759
[TBL] [Abstract][Full Text] [Related]
35. [
Fang Y; Wang S; Yang Q; You S; Xing X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jun; 42(6):905-912. PubMed ID: 35790442
[TBL] [Abstract][Full Text] [Related]
36. Streptococcal Extracellular Membrane Vesicles Are Rapidly Internalized by Immune Cells and Alter Their Cytokine Release.
Mehanny M; Koch M; Lehr CM; Fuhrmann G
Front Immunol; 2020; 11():80. PubMed ID: 32117243
[TBL] [Abstract][Full Text] [Related]
37. Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231.
Ding T; Yang LJ; Zhang WD; Shen YH
J Pharm Pharmacol; 2020 Jul; 72(7):969-978. PubMed ID: 32246778
[TBL] [Abstract][Full Text] [Related]
38. Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer.
Speyer CL; Bukhsh MA; Jafry WS; Sexton RE; Bandyopadhyay S; Gorski DH
Breast Cancer Res Treat; 2017 Nov; 166(2):407-419. PubMed ID: 28780701
[TBL] [Abstract][Full Text] [Related]
39. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
[TBL] [Abstract][Full Text] [Related]
40. Imipramine Induces Apoptosis and Inhibits the Metastatic Potential of Triple-negative Breast Cancer Cells.
Chen SK; Lee W; Li YC; Hsu FT; Chen WT
Anticancer Res; 2023 Jul; 43(7):2985-2994. PubMed ID: 37351989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
